Evidence map›Paper›PMID 37710304›Full record

ArticleSystematic reviews2023

Establishing a health-based recommended occupational exposure limit for isoflurane using experimental animal data: a systematic review protocol.

Fréderique Struijs, Carlijn R Hooijmans, Marije Buijs, Albert Dahan, Sebastian Hoffmann, Romy Kiffen, Daniele Mandrioli, Julia Menon, Merel Ritskes-Hoitinga, Nel Roeleveld and 4 more

Open access · goldAbstract read
In one paragraph

Article in Systematic reviews, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 2 citations in OpenAlex.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 4 countries.

Fréderique Struijs *Radboud Institute for Biological and Environmental Sciences, Radboud University, Nijmegen, The Netherlands.
Carlijn R Hooijmans *Department of Anaesthesiology, Pain and Palliative Care, Radboud University Medical Center, Nijmegen, The Netherlands.
Marije BuijsRadboud Institute for Biological and Environmental Sciences, Radboud University, Nijmegen, The Netherlands.
Albert DahanLeiden University Medical Center, Leiden, The Netherlands.
Sebastian HoffmannThe Evidence-Based Toxicology Collaboration (EBTC), Johns Hopkins Bloomberg School of Public Health, Baltimore, USA.
Romy KiffenRadboud Institute for Biological and Environmental Sciences, Radboud University, Nijmegen, The Netherlands.
Daniele MandrioliCesare Maltoni Cancer Research Center, Ramazzini Institute, Bologna, Italy.
Julia MenonNetherlands Heart Institute, Utrecht, The Netherlands.
Merel Ritskes-HoitingaInstitute for Risk Assessment Sciences, University Utrecht, Utrecht, The Netherlands.
Nel RoeleveldDepartment for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands.
Anne de RuijterRadboud Institute for Biological and Environmental Sciences, Radboud University, Nijmegen, The Netherlands.
Gert Jan SchefferDepartment of Anaesthesiology, Pain and Palliative Care, Radboud University Medical Center, Nijmegen, The Netherlands.
Vivi SchlünssenDepartment of Public Health, Danish Ramazzini Centre, Aarhus University, Aarhus, Denmark.
Paul T J ScheepersRadboud Institute for Biological and Environmental Sciences, Radboud University, Nijmegen, The Netherlands. paul.scheepers@radboudumc.nl.ORCID http://orcid.org/0000-0001-8005-0910
Radboud University Nijmegen · NLAarhus University · DKIstituto Ramazzini · ITJohns Hopkins University · USLeiden University Medical Center · NLNetherlands Heart Institute · NLUtrecht University · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIsoflurane is used as an inhalation anesthetic in medical, paramedical, and veterinary practice. Epidemiological studies suggest an increased risk of miscarriages and malformations at birth related to maternal exposure to isoflurane and other inhalation anesthetics. However, these studies cannot be used to derive an occupational exposure level (OEL), because exposure was not determined quantitatively and other risk factors such as co-exposures to other inhalation anesthetics and other work-related factors may also have contributed to the observed adverse outcomes. The aim of this systematic review project is to assess all available evidence on the effects of isoflurane in studies of controlled exposures in laboratory animals to derive a health-based recommended OEL.

methodsA comprehensive search strategy was developed to retrieve all animal studies addressing isoflurane exposure from PubMed, EMBASE, and Web of Science. Title-abstract screening will be performed by machine learning, and full-text screening by one reviewer. Discrepancies will be resolved by discussion. We will include primary research in healthy, sexually mature (non human) vertebrates of single exposure to isoflurane. Studies describing combined exposure and treatments with >  = 1 vol% isoflurane will be excluded. Subsequently, details regarding study identification, study design, animal model, and intervention will be summarized. All relevant exposure characteristics and outcomes will be extracted. The risk of bias will be assessed by two independent reviewers using an adapted version of the SYRCLE's risk of bias tool and an addition of the OHAT tool. For all outcomes for which dose-response curves can be derived, the benchmark dose (BMD) approach will be used to establish a point of departure for deriving a recommended health-based recommended OEL for 8 h (workshift exposure) and for 15 min (short-term exposure). DISCUSSION: Included studies should be sufficiently sensitive to detect the adverse health outcomes of interest. Uncertainties in the extrapolation from animals to humans will be addressed using assessment factor. These factors are justified in accordance with current practice in chemical risk assessment. A panel of experts will be involved to reach consensus decisions regarding significant steps in this project, such as determination of the critical effects and how to extrapolate from animals to humans. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42022308978.

Indexed as

Anesthetics, InhalationIsofluraneOccupational ExposureAnimalsAnimals, LaboratoryFemaleHumansInfant, NewbornSystematic Reviews as TopicAnesthetics, InhalationIsofluraneAnimal studiesInhalation anestheticOccupational exposureReproductive and developmental toxicityWork place standard

Identifiers

PMID37710304
PMCPMC10503167
OpenAlexW4386741334

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.